Labeler
Celgene Corporation NDC Codes
Celgene Corporation lists 27 finished drug products in the FDA NDC Directory under NDC labeler code 59572.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Revlimid, Pomalyst, Thalomid, Onureg, Reblozyl, Idhifa, Abecma, ZEPOSIA 7-Day Starter Pack, Zeposia, ZEPOSIA Starter Kit, Inrebic, Istodax, Vidaza
- Active ingredients
- Lenalidomide, Pomalidomide, Thalidomide, Azacitidine, Luspatercept, Enasidenib mesylate, Idecabtagene vicleucel, Ozanimod hydrochloride, Fedratinib hydrochloride
- NDC labeler codes
- 59572
- Strengths
- Idecabtagene vicleucel 300000000 1/1; Azacitidine 200 mg/1; Azacitidine 300 mg/1; Ozanimod hydrochloride .92 mg/1; Luspatercept 25 mg/1; Luspatercept 75 mg/1; Fedratinib hydrochloride 100 mg/1; Enasidenib mesylate 50 mg/1; Enasidenib mesylate 100 mg/1; Lenalidomide 20 mg/1; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1; Pomalidomide 3 mg/1; Pomalidomide 4 mg/1; Lenalidomide 2.5 mg/1; Thalidomide 150 mg/1; Lenalidomide 15 mg/1; Lenalidomide 25 mg/1; Lenalidomide 5 mg/1; Lenalidomide 10 mg/1
- Dosage forms
- Capsule, Tablet, Film coated, Kit, Injection, Powder, Lyophilized, For solution, Suspension
- Routes
- Oral, Subcutaneous, Intravenous
- Drug classes (FDA established)
- Thalidomide Analog, Nucleoside Metabolic Inhibitor, Erythroid Maturation Agent, Isocitrate Dehydrogenase 2 Inhibitor, Sphingosine 1-phosphate Receptor Modulator
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 42
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Abecmaidecabtagene vicleucel | Idecabtagene vicleucel 300000000 1/1 | SuspensionIntravenous | 59572-515 | 59572-0515-0159572-0515-0259572-0515-03 | — |
| Onuregazacitidine | Azacitidine 200 mg/1 | Tablet, Film coatedOral | 59572-730 | 59572-0730-07 | — |
| Onuregazacitidine | Azacitidine 300 mg/1 | Tablet, Film coatedOral | 59572-740 | 59572-0740-07 | — |
| ZEPOSIA 7-Day Starter Packozanimod hydrochloride | — | Kit | 59572-810 | 59572-0810-0759572-0810-97 | — |
| Zeposiaozanimod hydrochloride | Ozanimod hydrochloride .92 mg/1 | CapsuleOral | 59572-820 | 59572-0820-30 | — |
| ZEPOSIA Starter Kitozanimod hydrochloride | — | Kit | 59572-890 | 59572-0890-2859572-0890-98 | — |
| Reblozylluspatercept | Luspatercept 25 mg/1 | Injection, Powder, Lyophilized, For solutionSubcutaneous | 59572-711 | 59572-0711-01 | — |
| Reblozylluspatercept | Luspatercept 75 mg/1 | Injection, Powder, Lyophilized, For solutionSubcutaneous | 59572-775 | 59572-0775-01 | — |
| Inrebicfedratinib hydrochloride | Fedratinib hydrochloride 100 mg/1 | CapsuleOral | 59572-720 | 59572-0720-12 | — |
| Idhifaenasidenib mesylate | Enasidenib mesylate 50 mg/1 | Tablet, Film coatedOral | 59572-705 | 59572-0705-30 | — |
| Idhifaenasidenib mesylate | Enasidenib mesylate 100 mg/1 | Tablet, Film coatedOral | 59572-710 | 59572-0710-30 | — |
| Revlimidlenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 59572-420 | 59572-0420-0059572-0420-21 | — |
| Pomalystpomalidomide | Pomalidomide 1 mg/1 | CapsuleOral | 59572-501 | 59572-0501-0059572-0501-21 | — |
| Pomalystpomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | 59572-502 | 59572-0502-0059572-0502-21 | — |
| Pomalystpomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | 59572-503 | 59572-0503-0059572-0503-21 | — |
| Pomalystpomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | 59572-504 | 59572-0504-0059572-0504-21 | — |
| Revlimidlenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 59572-402 | 59572-0402-0059572-0402-28 | — |
| Istodaxromidepsin | — | Kit | 59572-984 | 59572-0984-01 | — |
| Thalomidthalidomide | Thalidomide 150 mg/1 | CapsuleOral | 59572-215 | 59572-0215-93 | — |
| Revlimidlenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 59572-415 | 59572-0415-0059572-0415-21 | — |
| Revlimidlenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 59572-425 | 59572-0425-0059572-0425-21 | — |
| Revlimidlenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 59572-405 | 59572-0405-0059572-0405-28 | — |
| Revlimidlenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 59572-410 | 59572-0410-0059572-0410-28 | — |
| Vidazaazacitidine | Azacitidine 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 59572-102 | 59572-0102-01 | — |
| Thalomidthalidomide | Thalidomide 50 mg/1 | CapsuleOral | 59572-205 | 59572-0205-9459572-0205-97 | — |
| Thalomidthalidomide | Thalidomide 100 mg/1 | CapsuleOral | 59572-210 | 59572-0210-95 | — |
| Thalomidthalidomide | Thalidomide 200 mg/1 | CapsuleOral | 59572-220 | 59572-0220-96 | — |
Celgene Corporation: common questions
- What is Celgene Corporation's NDC labeler code?
- 59572. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Celgene Corporation?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.